TXNRD1 and hepatocellular carcinoma: SLC22A7, which was downregulated in HCC yet specifically expressed in malignant cells, has been reported to affect mitochondrion and oxidoreductase in noncancerous liver tissues, thereby promoting the occurrence of HCC (42).